BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16447133)

  • 1. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association.
    Tan L;
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions.
    Klein JO; Myers MG
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S97-103. PubMed ID: 16447139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The United States pediatric vaccine stockpile program.
    Lane KS; Chu SY; Santoli JM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing government-operated vaccine programs: an industry perspective.
    Paradiso PR
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S118-20. PubMed ID: 16447132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee.
    Santoli JM; Peter G; Arvin AM; Davis JP; Decker MD; Fast P; Guerra FA; Helms CM; Hinman AR; Katz R; Klein JO; Koslap-Petraco MB; Paradiso PR; Schaffner W; Whitley-Williams PN; Williamson DE; Gellin B;
    JAMA; 2003 Dec; 290(23):3122-8. PubMed ID: 14679275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keys to strengthening the supply of routinely recommended vaccines: view from industry.
    Pisano W
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S111-7. PubMed ID: 16447131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002.
    Evans G
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S130-7. PubMed ID: 16447135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.
    Rodewald LE; Orenstein WA; Mason DD; Cochi SL
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
    Shrestha SS; Wallace GS; Meltzer MI
    Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
    Noah L
    S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider.
    Orenstein WA; Schaffner W
    Am J Med; 2008 Jul; 121(7 Suppl 2):S22-7. PubMed ID: 18589064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A response to strategy #2: streamlining the regulatory process.
    Glezen WP
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S141-4. PubMed ID: 16447137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stockpile levels for pediatric vaccines: how much is enough?
    Jacobson SH; Sewell EC; Proano RA; Jokela JA
    Vaccine; 2006 Apr; 24(17):3530-7. PubMed ID: 16522344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health. U.S. vaccine supply falls seriously short.
    Cohen J
    Science; 2002 Mar; 295(5562):1998-2001. PubMed ID: 11896251
    [No Abstract]   [Full Text] [Related]  

  • 16. Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005.
    Klein JO; Helms CM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S145-50. PubMed ID: 16447138
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing influenza vaccine utilization in physician offices serving adult patients: experience during a season of vaccine delays and shortages.
    Iwane MK; Singleton JA; Walton K; Coulen C; Wooten K
    J Public Health Manag Pract; 2007; 13(3):307-13. PubMed ID: 17435498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting the nation's health: ensuring a stable supply of influenza vaccine.
    Seiguer E
    Issue Brief (Commonw Fund); 2005 Jul; (832):1-14. PubMed ID: 16193600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the 2004-2005 influenza vaccine shortage on pediatric practice: a national survey.
    McQuillan L; Daley MF; Stokley S; Crane LA; Beaty BL; Barrow J; Babbel C; Dickinson LM; Kempe A
    Pediatrics; 2009 Feb; 123(2):e186-92. PubMed ID: 19171569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a severe influenza vaccine shortage on primary care practice.
    Kempe A; Daley MF; Stokley S; Crane LA; Beaty BL; Barrow J; Babbel C; Dickinson LM; Steiner JF; Berman S
    Am J Prev Med; 2007 Dec; 33(6):486-91. PubMed ID: 18022065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.